Conway Kevin John (CIK 2051408) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-09). Recent activity: Sell GBIO (2,072 shares), Buy GBIO (235 shares), Sell GBIO (72 shares), Buy GBIO (59 shares), Sell GBIO (17 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-09 | Generation Bio Co. (GBIO) | CHIEF FINANCIAL OFFICER | Sell | 2,072 | $0 |
| 2026-02-04 | Generation Bio Co. (GBIO) | Chief Financial Officer | Buy | 235 | $0 |
| 2026-02-04 | Generation Bio Co. (GBIO) | Chief Financial Officer | Sell | 72 | $406 |
| 2026-01-16 | Generation Bio Co. (GBIO) | Chief Financial Officer | Buy | 59 | $0 |
| 2026-01-16 | Generation Bio Co. (GBIO) | Chief Financial Officer | Sell | 17 | $96 |
| 2025-10-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Buy | 58 | $0 |
| 2025-10-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Sell | 18 | $121 |
| 2025-07-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Buy | 587 | $0 |
| 2025-07-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Sell | 173 | $74 |
| 2025-04-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Buy | 587 | $0 |
| 2025-04-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Sell | 173 | $64 |
| 2025-01-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Buy | 587 | $0 |
| 2025-01-17 | Generation Bio Co. (GBIO) | Chief Financial Officer | Sell | 204 | $182 |
Source: SEC Form 4 filings · as of 2026-02-09